查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629315

栓塞治療市場，按產品、按應用、按最終用途、按程序、按國家和地區 - 2025-2032 年全球行業分析、市場規模、市場佔有率和預測

Embolotherapy Market, By Product, By Application, By End Use, By Procedure, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2024 年，栓塞治療市場規模為 41.152 億美元，2025 年至 2032 年複合年成長率為 8.60%。

栓塞治療市場-市場動態

由於目標患者庫的擴大而增加目標手術

由於目標患者群體不斷擴大，目標手術數量也隨之增加，栓塞治療設備市場在過去十年中穩步成長。 CVD是一種主要目標疾病，由於其重要性和高發病率，成功有效的治療方法的研究一直集中在它身上。截至 2017 年，全球有超過 2 億人患有周邊血管疾病。此外，肝細胞癌和肝癌的盛行率不斷增加，以及與栓塞治療相關的高成功率和低術後併發症發生率，將在不久的將來增加對栓塞治療設備的需求。女性第九大最常見癌症和男性第五大最常見癌症是肝癌。 2018年，全球新診斷病例超過84萬例。男性發病率增加38%，女性發病率增加44%。

栓塞治療市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2025-2032 年）每年將以 8.60% 左右的複合年成長率成長

根據產品細分，預計栓塞劑將在 2024 年呈現最大市場佔有率

根據最終用途細分，醫院和診所是 2024 年的領先細分市場

根據手術細分，經導管動脈栓塞術是2024年的主導細分領域

按地區分類，北美是 2024 年的主要收入來源

栓塞治療市場區隔分析：

全球栓塞治療市場根據產品、應用、最終用途、程序和地區進行細分。

根據產品，市場分為栓塞彈簧圈（可推式彈簧圈、可拆卸彈簧圈）、可拆卸球囊、栓塞劑（微球、液體栓塞劑）、栓塞系統和支撐裝置（微導管、導絲） 。到 2024 年，栓塞治療市場將由栓塞劑主導。此外，由於藥物洗脫微球、用於溫和栓塞的校準微球以及用於原發性或繼發性肝病的放射性釔90微球等藥物的發展，預計該類別在預測期內將以最快的速度成長。由於微球經常用於治療 HCC，其使用的增加直接增加了對它們的需求。美國癌症協會報告稱，全球每年診斷出約 85 萬例肝癌。此外，推動這一類別的另一個重要因素是對創造多用途和可生物分解微球的持續研究。透過將化療藥物與治療性放射性核素結合，這些微球可以為 HCC 提供有效的治療。

根據最終用途，市場分為醫院和診所、門診手術中心（ASC）和其他。 2024年，醫院和診所類別佔據主導市場。栓塞劑和栓塞治療設備的主要最終消費者是重症監護病房、小型診所和大型醫院。在這些地區，擴大使用微創外科手術（例如血管、神經和泌尿外科干預措施），推動了栓塞治療手術的數量。對於栓塞手術，擁有完善的基礎設施、有利於全方位病患照護的設施（例如介入放射科）受到青睞。醫院對栓塞治療設備和栓塞劑的需求更大，因為醫院的病人比門診手術中心更多。大型醫療保健提供者不斷成長的購買力以及美國和其他重要歐洲市場的栓塞治療程序報銷也推動了這一類別的擴張。

栓塞治療市場 - 地理洞察

2024年，北美因其高度發展和先進的醫療基礎設施而佔據最大的栓塞治療市場佔有率，其中包括擁有最新栓塞治療技術的專科中心、介入放射科和最先進的醫療設施。特別是在美國，醫療保健支出是世界上最高的。除了促進尖端技術的採用外，對醫療保健資源的大量投資也使栓塞療法等現代醫療程序更加普及。北美的醫療保健人員素質高、經驗豐富，包括專業護理人員和介入放射科醫生。栓塞治療的有效實施和發展取決於技術人員的可用性。該地區也處於技術進步和醫學研究的前沿。

預計亞太地區將佔據相當大的市場佔有率。在亞太國家，癌症、周邊血管疾病和神經系統疾病等慢性疾病呈現上升趨勢。由於這些情況非常適合栓塞手術，因此該地區對栓塞工具和程序的需求不斷增加。在亞太地區，政府和私人醫療保健提供者正在加大對最先進醫療技術和醫療保健基礎設施的投資。全球所有新癌症病例中 50% 發生在亞太地區，到 2030 年，亞洲癌症相關死亡人數預計將增加 36%。世界經濟論壇預計，到 2024 年，全球 58% 的子宮頸癌死亡和 45% 的乳癌診斷發生在亞洲。因此，預計上述因素將保持該地區的領先地位。

栓塞治療市場-競爭格局：

栓塞治療市場的主要參與者包括Terumo Corporation、Merit Medical Systems, Inc.、Simbionix USA Corporation、Cook、Boston Scientific Corporation、Penumbra, Inc.、Meril Life Sciences Pvt.。有限公司、美敦力等。市場上的公司一直專注於創新。提供更有效的解決方案來回應不斷變化的最終用戶需求是一個主要焦點。由於參與者眾多，栓塞治療市場被認為相當分散。此外，產業參與者已將合作夥伴關係作為擴大產品範圍和地理影響力的重要策略。例如，2023 年 12 月，Terumo Medical Corporation 的創新 AZUR HydroPack 外圍線圈系統在美國推出。 AZUR HydroPack 線圈系統採用鉑金和水凝膠線圈，具有靈活的通用形狀，用於定位和填充容器內的空間。

近期發展

2024 年 6 月：波士頓科學公司宣布計畫收購總部位於矽谷的醫療器材公司 Silk Road Medical Inc.。透過一種稱為經頸動脈血管重建的微創治療，後者提供了幫助頸動脈疾病患者避免中風的產品。

2024 年 2 月：法國領先的醫學影像人工智慧專家 AI 宣佈建立策略合作夥伴關係，將其獲得 CE 標誌的 CINA-iPE 解決方案整合到 Blackford AI 平台中。此次合作為醫療專業人員提供了最先進的資源，可以在標準 CT 掃描過程中更準確地檢測偶發性肺栓塞。

2023 年 9 月：瑞典 CDMO 和可分解澱粉微球供應商 Magle Group 與 Sirtex Medical 宣布達成獨家全球分銷協議。作為合作的一部分，Sirtex Medical 在新市場和現有市場獨家經銷 Magle Group 的 EmboCept S DSM 50 μm 化療栓塞產品。

目錄

第1章：栓塞治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品分類的栓塞療法市場片段
    • 按應用分類的栓塞治療市場片段
    • 以最終用途分類的栓塞治療市場片段
    • 按程序分類的栓塞治療市場片段
    • 按國家/地區分類的栓塞治療市場片段
    • 按地區分類的栓塞治療市場片段
  • 競爭洞察

第 3 章：栓塞療法主要市場趨勢

  • 栓塞治療市場促進因素
    • 市場促進因素的影響分析
  • 栓塞治療市場限制
    • 市場限制影響分析
  • 栓塞治療市場機會
  • 栓塞治療市場未來趨勢

第 4 章：栓塞療法產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：栓塞治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：栓塞治療市場格局

  • 2024 年栓塞治療市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：栓塞治療市場 - 副產品

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 栓塞線圈
      • 可推線圈
      • 可拆卸線圈
    • 可拆卸氣球
    • 栓塞劑
      • 微球
      • 液態栓塞劑
    • 栓塞系統
    • 支援設備
      • 微導管
      • 導絲

第 8 章：栓塞治療市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 腫瘤學
      • 肺癌
      • 腎癌
      • 肝癌
      • 乳癌
      • 其他癌症
    • 周圍血管疾病
    • 泌尿外科和腎臟病學
      • 子宮肌瘤
      • 良性攝護腺增生
      • 其他泌尿科和腎臟科應用
    • 神經病學
      • 腦動靜脈畸形
      • 腦動脈瘤
    • 胃腸道疾病

第 9 章：栓塞治療市場 - 依最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 醫院和診所
    • 門診手術中心 (ASC)
    • 其他

第 10 章：栓塞治療市場 - 按程序

  • 概述
    • 按程序分類的細分市場佔有率分析
    • 經導管動脈栓塞術
    • 經動脈化療栓塞術
    • 經導管動脈放射栓塞/選擇性內放射治療

第 11 章：栓塞治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美栓塞療法主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用途）
    • 北美市場規模和預測（按程序）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲栓塞療法主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按產品）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用途）
    • 歐洲市場規模和預測（按程序）
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區栓塞療法主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按產品）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用途）
    • 亞太地區市場規模與預測（按程序）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲栓塞療法主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 拉丁美洲市場規模與預測（按程序）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲栓塞療法主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用途）
    • 中東和非洲市場規模及預測（按程序）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 栓塞治療產業

  • 競爭儀表板
  • 公司簡介
    • Terumo Corporation
    • Merit Medical Systems, Inc.
    • Simbionix USA Corporation
    • Cook
    • Boston Scientific Corporation
    • Penumbra, Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Medtronic
    • BTG International Limited
    • ABK Biomedical
    • Abbott
    • AngioDynamics
    • IMBIOTECHNOLOGIES LTD.
    • Debakey Medlife Private Limited
    • Heraeus Holding
    • Guerbet
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • BD
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4488

REPORT HIGHLIGHT

Embolotherapy Market size was valued at US$ 4,115.2 Million in 2024, expanding at a CAGR of 8.60% from 2025 to 2032.

Embolotherapy is the practice of treating or halting uncontrollable bleeding by blocking arteries with a device (such as a balloon catheter). By using this method, bleeding is managed, and tumours are decreased. By limiting abnormal blood vessels, this endovascular technique aims to halt bleeding. Postpartum conditions, pelvic tract bleeding, and cervical uprooted pregnancy are the main conditions treated with embolotherapy. Lesions to the liver, spleen, and kidneys are among the vascular, non-operative, and iatrogenic solid organ damage that this treatment has demonstrated potential to treat. Embolotherapy is used to remove duodenal varices, revascularize tissues and organs before surgery, and treat enlarged uterine fibroids. Selecting an embolization agent with the required degree of vascular blockage persistence is therefore required. The need for embolotherapy will expand due to the growing prevalence of liver and hepatic cancers, as well as the top manufacturers' heightened focus on technological advancements. Additionally, increased infrastructure construction expenses and better research & development skills to promote healthcare technology will drive growth in the embolotherapy market. Growing patient demand for minimally invasive procedures and increased personal disposable income are other factors driving market expansion.

Embolotherapy Market- Market Dynamics

Increase in target procedures due to the expanding target patient pool

The market for embolotherapy devices has grown steadily over the past ten years as a result of an increase in target procedures due to the expanding target patient pool. CVD is a major target illness, and because of its significance and high incidence, research on successful and efficient treatments has focused on it. Globally, more than 200 million people had peripheral vascular disorders as of 2017. The same source claims that the prevalence of these illnesses increases with age, with a prevalence rate of more than 20% seen in the over-80 age range. Moreover, The increasing prevalence of hepatocellular and liver cancers, along with the high success rate and low rate of post-operative complications linked to embolotherapy treatments, will increase the need for embolotherapy devices in the near future. The ninth most prevalent cancer in women and the fifth most common in men is liver cancer. More than 840,000 new cases were diagnosed worldwide in 2018. In addition, the UK had a 42% increase in kidney cancer incidence rates during the previous ten years. There was a 38% incidence rate in males and a 44% increase rate in females.

Embolotherapy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.60% over the forecast period (2025-2032)

Based on product segmentation, the embolic agents were predicted to show maximum market share in the year 2024

Based on end use segmentation, hospitals and clinics were the leading segment in 2024

Based on procedure segmentation, Transcatheter Arterial Embolization was the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Embolotherapy Market- Segmentation Analysis:

The Global Embolotherapy Market is segmented on the basis of Product, Application, End Use, Procedure, and Region.

On the basis of product, the market is segregated into Embolization Coil (Pushable Coils, Detachable Coils), Detachable Balloons, Embolic Agents (Microspheres, Liquid Embolic Agents), Embolic Plug Systems, and Support Devices (Microcatheters, Guidewires). The market for embolotherapy is dominated by embolic agents in 2024. For the most part, this segment dominates the market because of the growing usage of embolic agents in several interventional radiological treatments. Additionally, the category is anticipated to grow at the fastest rate during the forecast period due to the developments in such agents, such as drug-eluting microspheres, calibrated microspheres for bland embolization, and radioactive yttrium-90 microspheres for primary or secondary liver diseases. Since microspheres are frequently employed to treat HCC, their increasing use directly contributes to the demand for them. The American Cancer Society reports that about 850,000 liver cancer diagnoses are made worldwide each year. Moreover, another important factor propelling this category is the continuous study of creating multipurpose and biodegradable microspheres. By combining chemotherapeutic drugs with therapeutic radionuclides, these microspheres can provide an efficient treatment for HCC.

Based on end use, the market is divided into Hospitals and Clinics, Ambulatory Surgical Centers (ASCs), and Others. In 2024, the hospitals and clinics category held a dominant market share. The primary end consumers of embolic agents and embolotherapy equipment are critical care units, minor clinics, and large hospitals. At these locations, the number of embolotherapy procedures is being driven by the growing use of minimally invasive surgical procedures, such as vascular, neurological, and urological interventions. For embolization operations, facilities with established infrastructure that facilitates all-encompassing patient care-such as interventional radiology departments-are favoured. There is a greater need for embolotherapy equipment and embolic agents in hospitals because they have more patients than ambulatory surgery centres. The expansion of this category is also fueled by the larger healthcare providers' growing purchasing power and the availability of reimbursement for embolotherapy procedures in the United States and other significant European markets.

Embolotherapy Market- Geographical Insights

In 2024, North America held the largest market share for embolotherapy because of its highly developed and advanced healthcare infrastructure, which includes specialist centres with the newest embolotherapy technology, interventional radiology departments, and state-of-the-art medical facilities. Particularly in the United States, healthcare spending is among the highest in the world. In addition to facilitating the adoption of cutting-edge technologies, the substantial investment in healthcare resources makes modern medical procedures, such as embolotherapy, widely accessible. The healthcare workforce in North America is highly qualified and experienced and includes specialized nursing personnel and interventional radiologists. The effective implementation and growth of embolotherapy treatments depend on the availability of skilled personnel. The area is also at the forefront of technical advancement and medical research.

The Asia-Pacific region is anticipated to account for a sizeable portion of the market. In Asia-Pacific nations, chronic illnesses like cancer, peripheral vascular disease, and neurological disorders are on the rise. The region's need for embolization tools and procedures is rising as a result of these situations being perfect candidates for embolization operations. In Asia Pacific, governments and private healthcare providers are investing more in state-of-the-art medical technology and healthcare infrastructure. 50% of all new cancer cases worldwide occur in Asia Pacific, and by 2030, the number of cancer-related fatalities in Asia is predicted to rise by 36%. In 2024, the World Economic Forum anticipated that 58% of cervical cancer fatalities and 45% of all breast cancer diagnoses globally occur in Asia. Therefore, it is anticipated that the elements above will maintain the region's leading position.

Embolotherapy Market- Competitive Landscape:

Key players in the embolotherapy market include Terumo Corporation, Merit Medical Systems, Inc., Simbionix USA Corporation, Cook, Boston Scientific Corporation, Penumbra, Inc., Meril Life Sciences Pvt. Ltd., Medtronic, and others. The market's companies have been concentrating on innovations. Offering more effective solutions in response to changing end-user needs is a major focus. The market for embolotherapy is thought to be fairly fragmented because of the large number of players. In addition, industry participants have made partnerships a crucial tactic in their efforts to broaden both their product offerings and their geographical presence. For instance, in December 2023, the innovative AZUR HydroPack Peripheral Coil System from Terumo Medical Corporation was introduced in the US. A platinum and hydrogel coil with a flexible, universal shape, the AZUR HydroPack Coil System is made to locate and fill space inside the vessel.

Recent Development

June 2024: Boston Scientific Corporation announced plans to buy Silk Road Medical Inc., a medical device firm based in Silicon Valley. Through a minimally invasive treatment called trans carotid artery revascularization, the latter provides products to help patients with carotid artery disease avoid strokes.

February 2024: Leading French medical imaging AI specialist AI announced a strategic partnership to integrate its CE-marked CINA-iPE solution into the Blackford AI Platform. This collaboration gives medical professionals cutting-edge resources to detect incidental pulmonary embolisms during standard CT scans more accurately.

September 2023: Magle Group, a Swedish CDMO and vendor of degradable starch microspheres, and Sirtex Medical announced an exclusive global distribution deal. Sirtex Medical exclusively distributes the EmboCept S DSM 50 μm chemoembolization product from Magle Group in both new and existing markets as part of the collaboration.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL EMBOLOTHERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • Simbionix USA Corporation
  • Cook
  • Boston Scientific Corporation
  • Penumbra, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Medtronic
  • BTG International Limited
  • ABK Biomedical
  • Abbott
  • AngioDynamics
  • IMBIOTECHNOLOGIES LTD.
  • Debakey Medlife Private Limited
  • Heraeus Holding
  • Guerbet
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • BD
  • Others

GLOBAL EMBOLOTHERAPY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Embolization Coil
  • Pushable Coils
  • Detachable Coils
  • Detachable Balloons
  • Embolic Agents
  • Microspheres
  • Liquid Embolic Agents
  • Embolic Plug Systems
  • Support Devices
  • Microcatheters
  • Guidewires

GLOBAL EMBOLOTHERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Lung Cancer
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Other Cancers
  • Peripheral Vascular Diseases
  • Urology and Nephrology
  • Uterine Fibroids
  • Benign Prostatic Hyperplasia
  • Other Urology and Nephrology Applications
  • Neurology
  • Cerebral Arteriovenous Malformations
  • Brain Aneurysm
  • GIT Disorders

GLOBAL EMBOLOTHERAPY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

GLOBAL EMBOLOTHERAPY MARKET, BY PROCEDURE- MARKET ANALYSIS, 2019 - 2032

  • Transcatheter Arterial Embolization
  • Transarterial Chemoembolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

GLOBAL EMBOLOTHERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Embolotherapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Embolotherapy Market Snippet by Product
    • 2.1.2. Embolotherapy Market Snippet by Application
    • 2.1.3. Embolotherapy Market Snippet by End Use
    • 2.1.4. Embolotherapy Market Snippet by Procedure
    • 2.1.5. Embolotherapy Market Snippet by Country
    • 2.1.6. Embolotherapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Embolotherapy Key Market Trends

  • 3.1. Embolotherapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Embolotherapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Embolotherapy Market Opportunities
  • 3.4. Embolotherapy Market Future Trends

4. Embolotherapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Embolotherapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Embolotherapy Market Landscape

  • 6.1. Embolotherapy Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Embolotherapy Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Embolization Coil
      • 7.1.2.1. Pushable Coils
      • 7.1.2.2. Detachable Coils
    • 7.1.3. Detachable Balloons
    • 7.1.4. Embolic Agents
      • 7.1.4.1. Microspheres
      • 7.1.4.2. Liquid Embolic Agents
    • 7.1.5. Embolic Plug Systems
    • 7.1.6. Support Devices
      • 7.1.6.1. Microcatheters
      • 7.1.6.2. Guidewires

8. Embolotherapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Oncology
      • 8.1.2.1. Lung Cancer
      • 8.1.2.2. Kidney Cancer
      • 8.1.2.3. Liver Cancer
      • 8.1.2.4. Breast Cancer
      • 8.1.2.5. Other Cancers
    • 8.1.3. Peripheral Vascular Diseases
    • 8.1.4. Urology and Nephrology
      • 8.1.4.1. Uterine Fibroids
      • 8.1.4.2. Benign Prostatic Hyperplasia
      • 8.1.4.3. Other Urology and Nephrology Applications
    • 8.1.5. Neurology
      • 8.1.5.1. Cerebral Arteriovenous Malformations
      • 8.1.5.2. Brain Aneurysm
    • 8.1.6. GIT Disorders

9. Embolotherapy Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Ambulatory Surgical Centers (ASCs)
    • 9.1.4. Others

10. Embolotherapy Market - By Procedure

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Procedure, 2024 & 2032 (%)
    • 10.1.2. Transcatheter Arterial Embolization
    • 10.1.3. Transarterial Chemoembolization
    • 10.1.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

11. Embolotherapy Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Embolotherapy Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Embolotherapy Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.9. France
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.9.6. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.10. Italy
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.10.6. Italy Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.11. Spain
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.12. United Kingdom
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.12.6. United Kingdom Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.13. Russia
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Russia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.14. Netherlands
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Netherlands Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.15. Sweden
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Sweden Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Embolotherapy Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.10. South Korea
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.10.6. South Korea Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.11. Japan
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.11.6. Japan Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Embolotherapy Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Embolotherapy Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Embolotherapy Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Terumo Corporation
    • 12.2.2. Merit Medical Systems, Inc.
    • 12.2.3. Simbionix USA Corporation
    • 12.2.4. Cook
    • 12.2.5. Boston Scientific Corporation
    • 12.2.6. Penumbra, Inc.
    • 12.2.7. Meril Life Sciences Pvt. Ltd.
    • 12.2.8. Medtronic
    • 12.2.9. BTG International Limited
    • 12.2.10. ABK Biomedical
    • 12.2.11. Abbott
    • 12.2.12. AngioDynamics
    • 12.2.13. IMBIOTECHNOLOGIES LTD.
    • 12.2.14. Debakey Medlife Private Limited
    • 12.2.15. Heraeus Holding
    • 12.2.16. Guerbet
    • 12.2.17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 12.2.18. BD
    • 12.2.19. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us